Tyra Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TYRA | AVBP | 2410.HK | COGT | FTRE | KROS | |
|---|---|---|---|---|---|---|
| Market cap | 1.48B | 665.16M | 1.21B | 5.46B | 2.01B | 214.73M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -7.8 | -3.6 | -6.1 | -26.3 | 18.6 | -1.6 |
| Price/book | 3.6 | 1.8 | 4.0 | 11.6 | 3.8 | 0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +44.20% | −28.97% | −80.24% | +115.40% | +75.31% | −30.80% |
| Today | +0.73% | +3.61% | +9.61% | +1.38% | −0.57% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All TYRA news ›INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tyra Biosciences, Inc. ("Tyra" or the "Company") (NASDAQ: TYRA). Such investors... NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP is investigating…
Tyra Biosciences, Inc. Rings the Nasdaq Stock Market Opening Bell
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA's in-house precision medicine platform, SNÅP,…
From the 4Search news index, newest first.
In the news
Mentioned with
Themes
Most coverage from
- nasdaq.com2
- prnewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.